Evidence map›Paper›PMID 18255011›Full record

ReviewCurrent diabetes reports2007

Examining diabetic nephropathy through the lens of mouse genetics.

Matthew D Breyer, Elena Tchekneva, Zhonghua Qi, Takamune Takahashi, Agnes B Fogo, Raymond C Harris

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current diabetes reports, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Heritability of periodontal bone loss in mice.Journal of periodontal research · 2015
    Article
  4. Article
  5. Article
  6. Limb regeneration is impaired in an adult zebrafish model of diabetes mellitus.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Matthew D BreyerBiotherapeutics Discovery Research, Lilly Research Labs, Eli Lilly and Company, 355 E. Merrill Street, Indianapolis, IN 46225, USA. breyerma@lilly.com
Elena Tchekneva
Zhonghua Qi
Takamune Takahashi
Agnes B Fogo
Raymond C Harris
Eli Lilly (United States) · US

Funding

Generating Mouse Mutants with Diabetic NephropathyU01DK061018 · NIDDK · VANDERBILT UNIVERSITY · PI HARRIS, RAYMOND C. · 2001 to 2010
$6.1M
NIDDK NIH HHS DK61018
6 · The paper itself

Abstract

Although diabetic nephropathy occurs in only a minority of patients with diabetes, it is the major cause of end-stage renal disease in the United States. Hyperglycemia and hypertension are important factors predisposing patients to diabetic nephropathy, but accumulating evidence points to critical genetic factors predisposing only a subset of patients with diabetes to nephropathy. It has been challenging to define the genes conferring risk for nephropathy in human populations. Comparative genomics using the robust genetic reagents available in laboratory mice should provide a complementary approach to defining genes that may predispose to diabetic nephropathy in mice and humans. This article reviews new studies to identify genetic risk factors for diabetic nephropathy and the unique approaches that may be used to elucidate the genetic pathogenesis of this disorder in mice.

Indexed as

AnimalsDiabetic NephropathiesMiceMice, Inbred StrainsMutagenesisQuantitative Trait Loci

Identifiers

PMID18255011
OpenAlexW2147256940

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.